Additional file 5 of Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients

dataset

posted on 2023-11-19, 05:34 authored by Christoff Odendaal, Emmalie A. Jager, Anne-Claire M. F. Martines, Marcel A. Vieira-Lara, Nicolette C. A. Huijkman, Ligia A. Kiyuna, Albert Gerding, Justina C. Wolters, Rebecca Heiner-Fokkema, Karen van Eunen, Terry G. J. Derks, Barbara M. Bakker

Additional file 5: Table S2. Full patient urine acylcarnitine profiles. Historical urine acylcarnitine data from symptomatic and asymptomatic MCADD patients.

Funding

H2020 Marie Skłodowska-Curie Actions Universitair Medisch Centrum Groningen

History

Usage metrics

Keywords

Medium-chain acyl-CoA dehydrogenase deficiency Mitochondrial fatty acid oxidation Personalised medicine Metabolite partitioning Kinetic modelling Phenotypic heterogeneity Inborn error of metabolism

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM